Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Bicara Therapeutics
Bicara Therapeutics
Medicenna Therapeutics, Inc.
University of Pittsburgh
Light Chain Bioscience - Novimmune SA
Sheba Medical Center